Europe Vascular Graft Market to Grow with a CAGR of 6.22% through 2028

Increasing demand for the technologically advanced products and alarming rise in end stage renal disease prevalence is expected to drive the Europe Vascular Graft Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Europe Vascular Graft Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Europe Vascular Graft Market stood at USD 715.48 Million in 2022 and is anticipated to grow with a CAGR of 6.22% in the forecast period, 2024-2028. Several factors are propelling the growth of the vascular graft market in Europe. The increasing prevalence of cardiovascular diseases and diabetes, an expanding geriatric population, and technological advancements in graft materials and surgical techniques are primary drivers.  Additionally, the rising adoption of minimally invasive procedures and an increase in healthcare expenditure in the region contribute to the market's growth. Government initiatives promoting cardiovascular health also play a significant role in driving the market.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Europe Vascular Graft Market”

 

The Vascular Graft Market in Europe is a rapidly emerging and thriving sector with significant growth potential. This growth can be attributed to various factors, including the region's ageing population and the corresponding increase in vascular diseases. As the population continues to age, the demand for vascular grafts is expected to rise, as these medical devices play a crucial role in redirecting blood flow from one area of the body to another.

A vascular graft is typically used in surgical procedures when a patient suffers from blocked arteries, which can lead to severe health complications if left untreated. The prevalence of conditions such as atherosclerosis and aneurysm, which require the use of vascular grafts, is on the rise in Europe. In fact, cardiovascular disease (CVD) is currently the leading cause of death in Europe, accounting for 45% of all deaths. This alarming statistic further underscores the importance of vascular grafts in the region. Technological advancements and medical innovations in the field of vascular grafts are also contributing to the market's growth. Companies are now developing bioengineered vascular grafts that are proving to be more effective and safer compared to their traditional counterparts. These innovative grafts are designed to be fully absorbed by the body, reducing the risk of infection and improving the long-term success rate of surgeries.

The European vascular graft market is buoyed by high healthcare expenditure and a well-developed healthcare infrastructure. Countries like Germany, the UK, and France are at the forefront of vascular graft surgeries, boasting well-established healthcare systems and higher healthcare expenditure. This favorable healthcare landscape further supports the growth of the market in the region. However, the market does face certain challenges. Stringent regulatory policies for product approval and the high cost of procedures can pose hurdles to market growth. Additionally, there is a risk of complications associated with graft implants, including infection, blockage, and graft failure, which may impede market expansion. Nevertheless, the overall outlook for the European vascular graft market remains positive. The market is expected to grow at a robust pace due to the combination of an ageing population, the increasing prevalence of vascular diseases, continuous medical advancements, and a strong healthcare system. As companies continue to innovate and regulations evolve to facilitate more streamlined product approvals, the future of the vascular graft market in Europe looks promising.

 

The Europe Vascular Graft Market is segmented into indication, raw material, end user industry, country distribution, and company.

Based on indication, endovascular Aneurysm Repair (EVAR) has emerged as the unequivocal leader in the vascular graft market in Europe, propelled by various factors. Primarily, EVAR stands out due to its minimally invasive nature, which not only translates to shorter hospital stays and reduced recovery time but also offers patients the benefit of experiencing less postoperative pain. This less invasive approach has gained immense popularity, especially in an aging population where the prevalence of cardiovascular diseases is on the rise. The demand for efficient and less stressful surgical procedures like EVAR has surged as patients seek advanced medical solutions that ensure a smoother road to recovery. Additionally, the dominance of EVAR in the vascular graft market can also be attributed to the well-established healthcare facilities and the widespread adoption of advanced medical procedures in Europe. The presence of state-of-the-art healthcare institutions equipped with cutting-edge technologies has further bolstered the prominence of EVAR as a preferred treatment option. With a strong emphasis on patient care and safety, healthcare providers in Europe continue to prioritize the adoption of innovative techniques like EVAR to deliver optimal outcomes for their patients.

 

Based on country, the United Kingdom is at the forefront of the Vascular Graft Market in Europe, and this leadership position can be attributed to several key factors. Firstly, the country boasts an advanced healthcare infrastructure that facilitates the seamless integration of cutting-edge technologies and best practices. This enables UK hospitals and clinics to be early adopters of innovative medical devices, including vascular grafts, thereby driving advancements in patient care.

Furthermore, the high incidence of cardiovascular diseases in the United Kingdom serves as a significant driver for the demand of vascular grafts. With a proactive approach towards healthcare funding, the UK government ensures that adequate resources are allocated to address the needs of patients requiring vascular graft interventions. This commitment to healthcare is further bolstered by the presence of a robust network of medical device manufacturers in the country, contributing to its dominant position in the European Vascular Graft Market. With its comprehensive healthcare system, strong government support, and a thriving ecosystem of medical device manufacturers, the United Kingdom continues to lead the way in providing advanced vascular graft solutions to patients across Europe.

 

Major companies operating in Europe Vascular Graft Market are:

• B Braun Medical A/S
• Cardinal Health Inc.
• Endologix llc
• Cook Medical
• Medtronic plc
• Terumo Corporation
• LeMaitre Vascular, Inc.
• Getinge AB
• C.R. Bard
• W.L. Gore and Associates, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The increasing prevalence of chronic heart diseases and the growing demand for minimally invasive (MI) procedures are driving a positive outlook for the market. Vascular grafts play a crucial role in bypass surgeries for the diagnosis and treatment of angina pectoris, heart attack, heart artery blockages, and other cardiovascular diseases (CVDs). The wide adoption of these products is also attributed to the rising incidence of high blood pressure and cholesterol levels caused by sedentary lifestyles and the steadily growing geriatric population. Moreover, the development of biodegradable three-dimensional (3D) printed polymeric vascular grafts that are mechanically compatible with vascular tissues, support neo-tissue formation and growth, and are environmentally friendly, is propelling market growth. Additionally, the extensive use of prosthetic grafts, such as electrospun PU vascular grafts, for complex vascular trauma, which reduces the risk of neointimal formation, is positively influencing market growth. Other contributing factors include the significant growth in the healthcare industry, extensive research and development (R&D) activities, and rapid technological advancements in next-generation tissue-engineered vascular grafts, all of which are driving the market forward.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Europe Vascular Graft Market By Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral V ascular Repair), By Raw Material (Polyester, ePTFE, Polyurethane, Polyamide, Biosynthetic), By End User Industry (Hospital, Ambulatory Surgery Center), By Country, Competition, Forecast & Opportunities, 2018-2018F”, has evaluated the future growth potential of Europe Vascular Graft Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Europe Vascular Graft Market.

Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com